(Q40601511)

21 September 2017

1 reference

title

5HT drugs in animal models of anxiety (English)

1 reference

21 September 2017

S L Handley

1

1 reference

PubMed ID

7871002

21 September 2017

J W McBlane

series ordinal

2

1 reference

21 September 2017

1 January 1993

1 reference

21 September 2017

8

1 reference

inferred from page(s)

published in

Psychopharmacology

1 reference

21 September 2017

112

1 reference

21 September 2017

13-20

1 reference

21 September 2017

1

1 reference

https://scigraph.springernature.com/pub.10.1007/bf02247358

21 September 2017

0 references

cites work

Neuroanatomical sites of action of 5-HT3 receptor agonist and antagonists for alteration of aversive behaviour in the mouse

1 reference

https://api.crossref.org/works/10.1007%2FBF02247358

Can social interaction be used to measure anxiety?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02247358

5-HT receptors: subtypes and second messengers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02247358

Characterization of MDL 73005EF as a 5-HT1A selective ligand and its effects in animal models of anxiety: comparison with buspirone, 8-OH-DPAT and diazepam

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02247358

Selective agonists and antagonists for 5-hydroxytryptamine receptor subtypes, and interactions with yohimbine and FG 7142 using the elevated plus-maze test in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02247358

The effects of p-chlorophenylalanine, a serotonin depletor, on avoidance acquisition, pain sensitivity and related behavior in the rat

21 January 2018

1 reference

12 December 2020

Tryptaminergic mechanisms in punished and nonpunished behavior.

1 reference

12 December 2020

Effects of ritanserin on aversive classical conditioning in humans.

1 reference

12 December 2020

Comparison of acute and chronic treatment of various serotonergic agents with those of diazepam and idazoxan in the rat elevated X-maze

1 reference

12 December 2020

Anticonflict effect of the putative serotonin receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT).

1 reference

12 December 2020

Opposite control mediated by central 5-HT1A and non-5-HT1A (5-HT1B or 5-HT1C) receptors on periaqueductal gray aversion

1 reference

12 December 2020

The involvement of nigral serotonin innervation in the control of punishment-induced behavioral inhibition in rats.

1 reference

12 December 2020

Effects of 5-HT1A receptor agonists and L-5-HTP in Montgomery's conflict test

1 reference

12 December 2020

Monoaminergic mechanisms in aversive brain stimulation

1 reference

12 December 2020

Actions and some interactions of 5-HT1A ligands in the elevated X-maze and effects of dorsal raphe lesions

1 reference

12 December 2020

Piperazine derivatives including the putative anxiolytic drugs, buspirone and ipsapirone, are agonists at 5-HT1A receptors negatively coupled with adenylate cyclase in hippocampal neurons

1 reference

12 December 2020

Buspirone: Action on serotonin receptors in calf hippocampus

1 reference

12 December 2020

Serotonin function in anxiety. II. Effects of the serotonin agonist MCPP in panic disorder patients and healthy subjects

1 reference

12 December 2020

Inhibition of Serotonin Synthesis by Para-Chlorophenylalanine in Patients with the Carcinoid Syndrome

1 reference

12 December 2020

Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat

1 reference

12 December 2020

Attenuation of chemically induced defence response by 5-HT1 receptor agonists administered into the periaqueductal gray

1 reference

12 December 2020

Modulation of baseline behavior in rats by putative serotonergic agents in three ethoexperimental paradigms

1 reference

12 December 2020

Antidepressant-like action of 5-HT1A agonists and conventional antidepressants in an animal model of depression.

1 reference

12 December 2020

5-HT-the disengaging transmitter?

1 reference

12 December 2020

The effects of p-chlorophenylalanine on experimentally induced conflict in the rat

1 reference

12 December 2020

Inhibition of serotonergic dorsal raphe neurons by systemic and iontophoretic administration of buspirone, a non-benzodiazepine anxiolytic drug.

1 reference

12 December 2020

The concept of selectivity in 5-HT receptor research

1 reference

12 December 2020

Serotonergic mechanisms in the behavioral effects of buspirone and gepirone.

1 reference

12 December 2020

Effects in the X-maze anxiety model of agents acting at 5-HT1 and 5-HT2 receptors

1 reference

12 December 2020

Recent developments in 5HT-related pharmacology of animal models of anxiety.

1 reference

12 December 2020

An assessment of the elevated X-maze for studying anxiety and anxiety-modulating drugs

1 reference

12 December 2020

The relative efficacy of buspirone, imipramine and placebo in panic disorder: A preliminary report

1 reference

12 December 2020

Effects of 8-OH-DPAT and buspirone in a passive avoidance test and in the elevated plus-maze test in rats

1 reference

12 December 2020

An evaluation of the elevated plus-maze test using the novel anxiolytic buspirone

1 reference

12 December 2020

Electrophysiological investigation of the adaptive response of the 5-HT system to the administration of 5-HT1A receptor agonists

1 reference

12 December 2020

The involvement of serotonin in psychiatric disorders and behaviour

1 reference

12 December 2020

5-HT and mechanisms of defence

1 reference

12 December 2020

Decreased reactivity to anxiolytics caused by early protein malnutrition in rats.

1 reference

12 December 2020

Effects of alpha-adrenoceptor agonists and antagonists in a maze-exploration model of ?fear?-motivated behaviour

1 reference

12 December 2020

Review of the side-effect profile of buspirone

1 reference

12 December 2020

Are serotonergic neurons involved in the control of anxiety and in the anxiolytic activity of benzodiazepines?

1 reference

12 December 2020

Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine

1 reference

12 December 2020

Benzodiazepines, putative anxiolytics and animal models of anxiety

1 reference

12 December 2020

Microinjection of propranolol into the dorsal periaqueductal gray causes an anxiolytic effect in the elevated plus-maze antagonized by ritanserin.

1 reference

12 December 2020

Blockade of potentiated startle responding in rats by 5-hydroxytryptamine1A receptor ligands

1 reference

12 December 2020

Clinical pharmacology of anxiolytics and antidepressants: a psychopharmacological perspective

1 reference

12 December 2020

Intra-hippocampal buspirone in animal models of anxiety.

1 reference

12 December 2020

Anxiogenic-like effects of mCPP and TFMPP in animal models are opposed by 5-HT1C receptor antagonists

1 reference

12 December 2020

1 reference

12 December 2020

Lack of effects of 5HT3 receptor antagonists in the social interaction and elevated plus-maze tests of anxiety in the rat.

1 reference

12 December 2020

Behavioural and biochemical consequences following activation of 5HT1-like and GABA receptors in the dorsal raphé nucleus of the rat.

1 reference

12 December 2020

Serotonin function in panic disorder: a double blind placebo controlled study with fluvoxamine and ritanserin

1 reference

12 December 2020

Effects of blockade of 5-HT2 receptors and activation of 5-HT1A receptors on the exploratory activity of rats in the elevated plus-maze.

1 reference

12 December 2020

The effects of benzodiazepines and serotonergic manipulations on punished responding

1 reference

12 December 2020

Emotional memory systems in the brain

1 reference

12 December 2020

The effect of intravenous L-tryptophan on prolactin and growth hormone and mood in healthy subjects.

1 reference

12 December 2020

Serotonergic modulation of the rat pup ultrasonic isolation call: studies with 5HT1 and 5HT2 subtype-selective agonists and antagonists

1 reference

12 December 2020

Benzodiazepines reduce the tolerance to reward delay in rats

1 reference

12 December 2020

5-HT1C receptors in the serotonergic control of periaqueductal gray induced aversion in rats.

1 reference

12 December 2020

Evidence that the amygdala is involved in benzodiazepine and serotonergic effects on punished responding but not on discrimination.

1 reference

12 December 2020

1 reference

12 December 2020

The influence of ritanserin, a serotonin antagonist, in anxiety disorders: a double-blind placebo-controlled study versus lorazepam

1 reference

12 December 2020

Receptor reserve for 5-hydroxytryptamine1A-mediated inhibition of serotonin synthesis: possible relationship to anxiolytic properties of 5-hydroxytryptamine1A agonists.

1 reference

12 December 2020

Ethologically-based animal models of anxiety disorders

1 reference

12 December 2020

Anxiogenic-like effect of infusing 1-(3-chlorophenyl) piperazine (mCPP) into the hippocampus.

1 reference

12 December 2020

Evidence that the amygdala is involved in the disinhibitory effects of 5-HT3 receptor antagonists

1 reference

12 December 2020

Selective interaction of novel anxiolytics with 5-hydroxytryptamine1A receptors.

1 reference

12 December 2020

Role of the amygdala and periaqueductal gray in anxiety and panic

1 reference

12 December 2020

Pharmacological characterisation of a modified social interaction model of anxiety in the rat.

1 reference

12 December 2020

Effect of metergoline on human anxiety.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02247358

1 reference

PubMed ID

7871002

Dimensions Publication ID

21 September 2017

0 references

1 reference

PubMed ID

7871002